Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human otc drug. By marketing category: OTC MONOGRAPH DRUG 5.
| Dosage form | NDCs |
|---|---|
| cream | 4 |
| lotion | 1 |
| Route | NDCs |
|---|---|
| topical | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| flageoli limited | 5 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| SERIOUS SKINCARE Continuously Clear Clearz It | BENZOYL PEROXIDE | cream, topical | 53755-392OTC MONOGRAPH DRUG |
| SERIOUS SKINCARE SERIOUS C3 PLASMA BIO TECHNOLOGY C VITAMIN C ESTER PROTECTIVE DAYTIME BROAD SPECTRUM MOISTURIZER SPF 30 | AVOBENZONE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, OXYBENZONE | cream, topical | 53755-101OTC MONOGRAPH DRUG |
| SERIOUS SKINCARE SERIOUS-C3 PLASMA TM BIO TECHNOLOGY C VITAMIN C ESTER PROTECTIVE DAYTIME BROAD SPECTRUM MOISTURIZER SPF 30 | AVOBENZONE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, OXYBENZONE | cream, topical | 53755-100OTC MONOGRAPH DRUG |
| Serious Skincare Continuously Clear Acne Medication For Problematic skin Dry Lo Pro All- Over Treatment | SALICYLIC ACID | lotion, topical | 53755-110OTC MONOGRAPH DRUG |
| Serious Skincare Serious-C3 Plasma Bio Technology C Cream SPF 30 | AVOBENZONE, OCTOCRYLENE, OCTINOXATE, OCTISALATE, OXYBENZONE | cream, topical | 53755-120OTC MONOGRAPH DRUG |
Enquiry
Common questions
- Is Flageoli Limited FDA approved?
- Flageoli Limited holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Flageoli Limited make?
- 5 products are listed under Flageoli Limited in the openFDA NDC Directory, most often as cream; lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.